EP Patent

EP3452598A4 — LIPOSOMAL SPHERIC NUCLEIC ACID (SNA) CONSTRUCTS WITH ANTISENSE OLIGONUCLEOTIDES (ASO) FOR THE SPECIFIC KNOCKDOWN OF INTERLEUKIN-17 RECEPTOR MRNA

Assigned to Exicure Operating Co · Expires 2020-04-29 · 6y expired

What this patent protects

Patent listed against nusinersen-sodium.

Drugs covered by this patent

nusinersen-sodium (NUSINERSEN SODIUM)

Patent Metadata

Patent number: EP3452598A4
Jurisdiction: EP
Classification: —
Expires: 2020-04-29
Drug substance claim: No
Drug product claim: No
Assignee: Exicure Operating Co
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.